Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $116.81 in the prior trading day, Encompass Health Corp (NYSE: EHC) closed at $113.85, down -2.53%. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 2.05 million shares were traded. EHC stock price reached its highest trading level at $117.15 during the session, while it also had its lowest trading level at $112.69.
Ratios:
Our goal is to gain a better understanding of EHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 89.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.48. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on October 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $115.
On July 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $100.
On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $95.Barclays initiated its Overweight rating on March 06, 2024, with a $95 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 27 ’25 when Tuer Patrick William sold 1,020 shares for $123.59 per share. The transaction valued at 126,062 led to the insider holds 18,846 shares of the business.
Patrick Tuer bought 1,020 shares of EHC for $126,062 on Aug 27 ’25. On May 20 ’25, another insider, Tarr Mark J, who serves as the President & CEO of the company, sold 118,384 shares for $121.53 each. As a result, the insider received 14,387,152 and left with 527,070 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EHC now has a Market Capitalization of 11467407360 and an Enterprise Value of 14880529408. As of this moment, Encompass’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.50, and their Forward P/E ratio for the next fiscal year is 19.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.98 while its Price-to-Book (P/B) ratio in mrq is 4.83. Its current Enterprise Value per Revenue stands at 2.568 whereas that against EBITDA is 11.26.
Stock Price History:
The Beta on a monthly basis for EHC is 0.93, which has changed by 0.1358875 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, EHC has reached a high of $127.99, while it has fallen to a 52-week low of $87.85. The 50-Day Moving Average of the stock is -8.36%, while the 200-Day Moving Average is calculated to be 0.87%.
Shares Statistics:
The stock has traded on average 745.60K shares per day over the past 3-months and 1050440 shares per day over the last 10 days, according to various share statistics. A total of 100.70M shares are outstanding, with a floating share count of 99.20M. Insiders hold about 1.51% of the company’s shares, while institutions hold 94.93% stake in the company. Shares short for EHC as of 1760486400 were 1656513 with a Short Ratio of 2.22, compared to 1757894400 on 1463322. Therefore, it implies a Short% of Shares Outstanding of 1656513 and a Short% of Float of 1.8499999999999999.
Dividends & Splits
In the trailing 12 months, EHC’s forward annual dividend rate was 0.7, compared to 0.70 this year. Against a Trailing Annual Dividend Yield of 0.0059926375. The stock’s 5-year Average Dividend Yield is 1.16. . The current Payout Ratio is 14.35% for EHC, which recently paid a dividend on 2025-10-01 with an ex-dividend date of 2026-01-02. Stock splits for the company last occurred on 2022-07-01 when the company split stock in a 1257:1000 ratio.
Earnings Estimates
The dynamic stock of Encompass Health Corp (EHC) is currently attracting attention from 12.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $1.5, with high estimates of $1.62 and low estimates of $1.4.
Analysts are recommending an EPS of between $5.35 and $5.25 for the fiscal current year, implying an average EPS of $5.3. EPS for the following year is $5.8, with 13.0 analysts recommending between $6.21 and $5.55.
Revenue Estimates
10 analysts predict $1.54B in revenue for . The current quarter. It ranges from a high estimate of $1.55B to a low estimate of $1.53B. As of . The current estimate, Encompass Health Corp’s year-ago sales were $1.41BFor the next quarter, 10 analysts are estimating revenue of $1.58B. There is a high estimate of $1.59B for the next quarter, whereas the lowest estimate is $1.57B.
A total of 10 analysts have provided revenue estimates for EHC’s current fiscal year. The highest revenue estimate was $5.94B, while the lowest revenue estimate was $5.92B, resulting in an average revenue estimate of $5.93B. In the same quarter a year ago, actual revenue was $5.37BBased on 11 analysts’ estimates, the company’s revenue will be $6.44B in the next fiscal year. The high estimate is $6.5B and the low estimate is $6.39B.
